Skip to main content
. 2019 Mar 29;10:646. doi: 10.3389/fimmu.2019.00646

Table 1.

Vaccination and challenge scheme.

Groups Vaccine (D 0, 10, 20) Route Vaccine dose (μg HA) adjuvant dose (μg) injection volume (μl) Challenge D 41
1 PBS i.m. 50
2 WIV i.m. 0.5 50
3 WIV+ CAF01 i.m. 0.5 300 50
4 WIV i.n. 0.5 40
5 WIV+ CAF09 i.n. 0.5 300 40 A/PR/8/34
6 WIV+ CTA1-DD i.n. 0.5 5 40 (H1N1)pdm09
7 WIV+ CTA1-3M2e-DD i.n. 0.5 5 40 X-31